DENTSPLY SIRONA Inc Gets a Hold Rating from Barclays

In a report released yesterday, Steven Valiquette from Barclays maintained a Hold rating on DENTSPLY SIRONA Inc (NASDAQ: XRAY), with a price target of $55. The company’s shares closed yesterday at $46.92, close to its 52-week low of $46.

According to TipRanks.com, Valiquette is a 4-star analyst with an average return of 8.3% and a 54.0% success rate. Valiquette covers the Services sector, focusing on stocks such as AmerisourceBergen Corporation, Walgreens Boots Alliance, and Patterson Companies Inc.

Currently, the analyst consensus on DENTSPLY SIRONA Inc is Moderate Buy and the average price target is $61.50, representing a 31.1% upside.

In a report released today, H.C. Wainwright also reiterated a Hold rating on the stock with a $52 price target.

Find more picks by Best Performing Analysts >>

Based on DENTSPLY SIRONA Inc’s latest earnings release for the quarter ending March 31, the company reported a quarterly net profit of $81.2 million. In comparison, last year the company had a net profit of $59.8 million.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

DENTSPLY SIRONA, Inc. engages in the design, manufacture, sales, and distribution of professional dental products and technologies. It operates through the Technologies and Equipment and Consumables segments.